-- VectorCertain introduces MRM-CFS, ultra-compact AI models for improved safety in edge cases. -- Existing AI systems fail on rare events; MRM-CFS offers precise detection and fusion solutions. -- ...

If you’ve ever wanted to drive the famous Tail of the Dragon without having to worry about crossing the mustard and ruining someone’s (and your) day, there’s a sim for that. At first blush, it looks ...

When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...

All the twists, turns, and thrills bridge North Carolina and Tennessee. Tail of the Dragon offers over 300 turns in less than 11 miles. The North Carolina entrance is sharper and more challenging; the ...

Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...

Monday - Friday, 6:00 - 7:00 PM ET It's that time again! "Mad Money" host Jim Cramer rings the lightning round bell, which means he's giving his answers to callers' stock questions at rapid speed.

This is this week’s ForbesWomen newsletter, which every Thursday brings news about the world’s top female entrepreneurs, leaders and investors straight to your inbox. Click here to get on the ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

Recursion Pharmaceuticals owns the largest supercomputer in the pharmaceutical industry. However, Eli Lilly is starting to build one that could be even more powerful once it's completed. With its ...

Interstellar comet 3I/ATLAS exhibits a bright, extended ion tail while releasing gas and dust as it travels through the inner solar system. When you purchase through links on our site, we may earn an ...

Recursion Pharmaceuticals has designated its top research executive, Najat Khan, to succeed co-founder Chris Gibson as president and chief executive of the clinical-stage biotechnology company, ...

After 12 years leading Utah-based techbio company Recursion, CEO Chris Gibson is stepping down. Recursion’s R&D head and Chief Commercial Officer Najat Khan will become CEO effective Jan. 1. Gibson co ...